{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:55:29Z","timestamp":1791888929348,"version":"4.3.4"},"reference-count":124,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2014,10,1]]},"DOI":"10.2106\/jbjs.m.01096","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T14:40:53Z","timestamp":1412174453000},"page":"1659-1668","source":"Crossref","is-referenced-by-count":163,"title":["A Review of Osteocyte Function and the Emerging Importance of Sclerostin"],"prefix":"10.2106","volume":"96","author":[{"given":"Jocelyn T.","family":"Compton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"10","key":"bib1-20210131","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med."},{"issue":"2","key":"bib2-20210131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.abb.2008.03.016","article-title":"Regulation of bone remodeling by the central and peripheral nervous system","volume":"473","author":"Elefteriou","year":"2008","journal-title":"Arch Biochem Biophys."},{"issue":"2","key":"bib3-20210131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2007.03.013","article-title":"Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology","volume":"115","author":"Weinstein","year":"2007","journal-title":"Pharmacol Ther."},{"issue":"Suppl 1","key":"bib4-20210131","article-title":"Regulation of energy metabolism by osteocytes","volume":"25","author":"Kwon","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib5-20210131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1210\/jc.2008-0270","article-title":"The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training","volume":"94","author":"Fern\u00e1ndez-Real","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"bib6-20210131","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib7-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1297-319X(00)00235-9","article-title":"Gonadal dysgenesis and bone metabolism","volume":"68","author":"Breuil","year":"2001","journal-title":"Joint Bone Spine."},{"issue":"1","key":"bib8-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(03)00241-3","article-title":"The osteocyte","volume":"36","author":"Knothe Tate","year":"2004","journal-title":"Int J Biochem Cell Biol."},{"issue":"8","key":"bib9-20210131","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2106\/00004623-199508000-00020","article-title":"Bone Biology","volume":"77","author":"Buckwalter","year":"1995","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib10-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/8756-3282(90)90134-K","article-title":"Morphological study of intercellular junctions during osteocyte differentiation","volume":"11","author":"Palumbo","year":"1990","journal-title":"Bone."},{"issue":"5","key":"bib11-20210131","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell ... and more [Epub ahead of print]","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev."},{"issue":"2","key":"bib12-20210131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib14-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00219008","article-title":"A three-dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos","volume":"246","author":"Palumbo","year":"1986","journal-title":"Cell Tissue Res."},{"issue":"2","key":"bib15-20210131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S8756-3282(00)00421-X","article-title":"A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy","volume":"28","author":"Kamioka","year":"2001","journal-title":"Bone."},{"issue":"4","key":"bib16-20210131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000146907","article-title":"Osteocyte differentiation in the tibia of newborn rabbit: an ultrastructural study of the formation of cytoplasmic processes","volume":"137","author":"Palumbo","year":"1990","journal-title":"Acta Anat (Basel)."},{"issue":"3","key":"bib17-20210131","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcb.240550304","article-title":"Function of osteocytes in bone","volume":"55","author":"Aarden","year":"1994","journal-title":"J Cell Biochem."},{"issue":"106","key":"bib18-20210131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00003086-197501000-00043","article-title":"Cellular control of calcium movements in bone. Interrelationships of the bone membrane, parathyroid hormone and alkaline phosphatase","author":"Ramp","year":"1975","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"bib19-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S8756-3282(97)00234-2","article-title":"In vivo tracer transport through the lacunocanalicular system of rat bone in an environment devoid of mechanical loading","volume":"22","author":"Knothe Tate","year":"1998","journal-title":"Bone."},{"issue":"1","key":"bib20-20210131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.20603","article-title":"Buried alive: how osteoblasts become osteocytes","volume":"235","author":"Franz-Odendaal","year":"2006","journal-title":"Dev Dyn."},{"issue":"1","key":"bib21-20210131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2009.05246.x","article-title":"Dynamics of the transition from osteoblast to osteocyte","volume":"1192","author":"Dallas","year":"2010","journal-title":"Ann N Y Acad Sci."},{"issue":"8","key":"bib22-20210131","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI10158","article-title":"Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen","volume":"106","author":"Zhao","year":"2000","journal-title":"J Clin Invest."},{"issue":"Pt 1","key":"bib23-20210131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1242\/jcs.01581","article-title":"The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone","volume":"118","author":"Holmbeck","year":"2005","journal-title":"J Cell Sci."},{"issue":"11","key":"bib24-20210131","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/jbmr.5650091105","article-title":"Characteristics and properties of osteocytes in culture","volume":"9","author":"van der Plas","year":"1994","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib25-20210131","first-page":"209","article-title":"Osteopetrosis with syndactyly; a morphological variant of Albers-Sch\u00f6nberg\u2019s disease","volume":"40","author":"Truswell","year":"1958","journal-title":"J Bone Joint Surg Br."},{"issue":"5","key":"bib26-20210131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet."},{"issue":"3","key":"bib27-20210131","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet."},{"issue":"6","key":"bib28-20210131","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"Suppl 1","key":"bib29-20210131","doi-asserted-by":"crossref","first-page":"i119","DOI":"10.1136\/ard.2010.141150","article-title":"Targeting sclerostin as potential treatment of osteoporosis","volume":"70","author":"Papapoulos","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"bib30-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"bib31-20210131","first-page":"94","article-title":"[Anti-sclerostin antibodies]","volume":"21","author":"Okazaki","year":"2011","journal-title":"Clin Calcium."},{"issue":"4","key":"bib32-20210131","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"7","key":"bib33-20210131","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","article-title":"Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism","volume":"26","author":"Atkins","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib34-20210131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0940-9602(98)80106-4","article-title":"Morphometric investigation on osteocytes in human auditory ossicles","volume":"180","author":"Marotti","year":"1998","journal-title":"Ann Anat."},{"issue":"9","key":"bib35-20210131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jbiomech.2005.04.032","article-title":"Osteocyte lacunae tissue strain in cortical bone","volume":"39","author":"Nicolella","year":"2006","journal-title":"J Biomech."},{"issue":"10","key":"bib36-20210131","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jbiomech.2006.10.040","article-title":"Tissue strain amplification at the osteocyte lacuna: a microstructural finite element analysis","volume":"40","author":"Bonivtch","year":"2007","journal-title":"J Biomech."},{"issue":"23","key":"bib37-20210131","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"issue":"4","key":"bib38-20210131","first-page":"354","article-title":"Mechanical stimulation in vivo reduces osteocyte expression of sclerostin","volume":"6","author":"Robling","year":"2006","journal-title":"J Musculoskelet Neuronal Interact."},{"issue":"9","key":"bib39-20210131","doi-asserted-by":"crossref","first-page":"E1736","DOI":"10.1210\/jc.2012-1579","article-title":"Serum sclerostin increases in healthy adult men during bed rest","volume":"97","author":"Spatz","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"bib40-20210131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jbmr.546","article-title":"Association between sclerostin and bone density in chronic spinal cord injury","volume":"27","author":"Morse","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"10","key":"bib41-20210131","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"10","key":"bib42-20210131","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"12","key":"bib43-20210131","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1210\/jc.2005-2370","article-title":"Sclerostin and Wnt signaling\u2014the pathway to bone strength","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"bib44-20210131","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2011.07.034","article-title":"High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes","volume":"49","author":"Niziolek","year":"2011","journal-title":"Bone."},{"issue":"20","key":"bib45-20210131","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem."},{"issue":"2","key":"bib46-20210131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14712598.2012.740006","article-title":"Monoclonal antibodies for the treatment of osteoporosis","volume":"13","author":"Lewiecki","year":"2013","journal-title":"Expert Opin Biol Ther."},{"issue":"2","key":"bib47-20210131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone."},{"issue":"3","key":"bib48-20210131","doi-asserted-by":"crossref","first-page":"e17772","DOI":"10.1371\/journal.pone.0017772","article-title":"Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression","volume":"6","author":"Genetos","year":"2011","journal-title":"PLoS One."},{"issue":"2","key":"bib49-20210131","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jcb.22559","article-title":"Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts","volume":"110","author":"Genetos","year":"2010","journal-title":"J Cell Biochem."},{"issue":"2","key":"bib50-20210131","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J Clin Invest."},{"issue":"12","key":"bib51-20210131","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"3","key":"bib52-20210131","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/endo.132.3.8440191","article-title":"The effect of leukemia inhibitory factor on bone in vivo","volume":"132","author":"Cornish","year":"1993","journal-title":"Endocrinology."},{"issue":"8","key":"bib53-20210131","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1359\/jbmr.090305","article-title":"Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts","volume":"24","author":"Vincent","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"5207","key":"bib54-20210131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.7701349","article-title":"A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia","volume":"268","author":"Schipani","year":"1995","journal-title":"Science."},{"issue":"3","key":"bib55-20210131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","article-title":"Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone","volume":"107","author":"Calvi","year":"2001","journal-title":"J Clin Invest."},{"issue":"11","key":"bib56-20210131","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"50","key":"bib57-20210131","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","article-title":"Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism","volume":"278","author":"Bellido","year":"2003","journal-title":"J Biol Chem."},{"issue":"11","key":"bib58-20210131","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology."},{"issue":"8","key":"bib59-20210131","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1359\/jbmr.060504","article-title":"Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen","volume":"21","author":"Zaman","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"9","key":"bib60-20210131","first-page":"3128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"bib61-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"4","key":"bib62-20210131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1530\/EJE-12-1074","article-title":"Serum sclerostin levels in men with idiopathic osteoporosis","volume":"168","author":"Lapauw","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"bib63-20210131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.22203\/eCM.v024a14","article-title":"Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of \u03b2-catenin","volume":"24","author":"J\u00e4hn","year":"2012","journal-title":"Eur Cell Mater."},{"issue":"4","key":"bib64-20210131","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1359\/jbmr.070115","article-title":"Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity","volume":"22","author":"Kayal","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib65-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bone.2008.10.042","article-title":"Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment","volume":"44","author":"Kayal","year":"2009","journal-title":"Bone."},{"issue":"10","key":"bib66-20210131","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/jbmr.5650091007","article-title":"Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization","volume":"9","author":"Hirakawa","year":"1994","journal-title":"J Bone Miner Res."},{"issue":"8","key":"bib67-20210131","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/jbmr.70","article-title":"Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture","volume":"25","author":"Power","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib68-20210131","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcdb.2008.07.004","article-title":"Bone remodeling during fracture repair: The cellular picture","volume":"19","author":"Schindeler","year":"2008","journal-title":"Semin Cell Dev Biol."},{"issue":"6","key":"bib69-20210131","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bone.2011.08.012","article-title":"Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene","volume":"49","author":"Li","year":"2011","journal-title":"Bone."},{"issue":"2","key":"bib70-20210131","first-page":"178","article-title":"Time-dependent effects of sclerostin antibody on a mouse fracture healing model","volume":"13","author":"Cui","year":"2013","journal-title":"J Musculoskelet Neuronal Interact."},{"issue":"8","key":"bib71-20210131","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2106\/JBJS.L.00285","article-title":"Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model","volume":"95","author":"Virk","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib72-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jor.22186","article-title":"Effects of sclerostin antibody on healing of a non-critical size femoral bone defect","volume":"31","author":"Jawad","year":"2013","journal-title":"J Orthop Res."},{"issue":"11","key":"bib73-20210131","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/jbmr.1984","article-title":"Sclerostin antibody stimulates bone regeneration after experimental periodontitis","volume":"28","author":"Taut","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"10","key":"bib74-20210131","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jor.22129","article-title":"Strongly enhanced levels of sclerostin during human fracture healing","volume":"30","author":"Sarahrudi","year":"2012","journal-title":"J Orthop Res."},{"issue":"2","key":"bib75-20210131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11914-009-0012-5","article-title":"Wnt signaling during fracture repair","volume":"7","author":"Secreto","year":"2009","journal-title":"Curr Osteoporos Rep."},{"issue":"8","key":"bib76-20210131","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1210\/jc.2013-1402","article-title":"Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial","volume":"98","author":"Anastasilakis","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"bib77-20210131","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib78-20210131","doi-asserted-by":"crossref","first-page":"e16947","DOI":"10.1371\/journal.pone.0016947","article-title":"Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing","volume":"6","author":"Caetano-Lopes","year":"2011","journal-title":"PLoS One."},{"issue":"10","key":"bib79-20210131","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jor.22109","article-title":"Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats","volume":"30","author":"McDonald","year":"2012","journal-title":"J Orthop Res."},{"issue":"5","key":"bib80-20210131","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"15","key":"bib81-20210131","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.biomaterials.2004.07.036","article-title":"Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles","volume":"26","author":"Grandjean-Laquerriere","year":"2005","journal-title":"Biomaterials."},{"issue":"29","key":"bib82-20210131","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1016\/j.biomaterials.2009.06.023","article-title":"Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro","volume":"30","author":"Lange","year":"2009","journal-title":"Biomaterials."},{"issue":"1-3","key":"bib83-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tox.2012.04.002","article-title":"Inhibitory effects of \u03b2-tricalciumphosphate wear particles on osteocytes via apoptotic response and Akt inactivation","volume":"297","author":"Zhang","year":"2012","journal-title":"Toxicology."},{"issue":"12","key":"bib84-20210131","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1002\/art.37697","article-title":"Sclerostin antibody prevents particle-induced implant loosening by stimulating bone formation and inhibiting bone resorption in a rat model","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"18","key":"bib85-20210131","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2106\/JBJS.K.00344","article-title":"Sclerostin antibody increases bone volume and enhances implant fixation in a rat model","volume":"94","author":"Virdi","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib86-20210131","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"8","key":"bib87-20210131","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1517\/14728222.2012.697154","article-title":"Sclerostin: a possible target for the management of cancer-induced bone disease","volume":"16","author":"Gkotzamanidou","year":"2012","journal-title":"Expert Opin Ther Targets."},{"issue":"20","key":"bib88-20210131","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2174\/092986711796391660","article-title":"Bone metastatic disease: taking aim at new therapeutic targets","volume":"18","author":"Coluzzi","year":"2011","journal-title":"Curr Med Chem."},{"issue":"3","key":"bib89-20210131","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/14728214.2011.576668","article-title":"Emerging therapies in metastatic bone pain","volume":"16","author":"Coluzzi","year":"2011","journal-title":"Expert Opin Emerg Drugs."},{"issue":"6","key":"bib90-20210131","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-09-2684","article-title":"RANK ligand and osteoprotegerin in myeloma bone disease","volume":"101","author":"Sezer","year":"2003","journal-title":"Blood."},{"issue":"6","key":"bib91-20210131","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/bcj.2011.22","article-title":"Myeloma cells suppress osteoblasts through sclerostin secretion","volume":"1","author":"Colucci","year":"2011","journal-title":"Blood Cancer J."},{"issue":"6","key":"bib92-20210131","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ijc.27342","article-title":"Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy","volume":"131","author":"Terpos","year":"2012","journal-title":"Int J Cancer."},{"issue":"3","key":"bib93-20210131","first-page":"478","article-title":"Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget's specimens","volume":"3","author":"Masrour Roudsari","year":"2012","journal-title":"Caspian J Intern Med."},{"issue":"1","key":"bib94-20210131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2012.04.013","article-title":"Pregnancy- and lactation-associated transient osteoporosis of both hips in a 32 year old patient with osteogenesis imperfecta","volume":"51","author":"Pabinger","year":"2012","journal-title":"Bone."},{"issue":"2","key":"bib95-20210131","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10585-013-9625-2","article-title":"Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment","volume":"31","author":"Larson","year":"2014","journal-title":"Clin Exp Metastasis."},{"issue":"18","key":"bib96-20210131","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-05-1891","article-title":"Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism","volume":"65","author":"Dai","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"bib97-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bone.2012.04.016","article-title":"Serum sclerostin levels in Paget\u2019s disease and prostate cancer with bone metastases with a wide range of bone turnover","volume":"51","author":"Yavropoulou","year":"2012","journal-title":"Bone."},{"issue":"10","key":"bib98-20210131","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One."},{"issue":"49","key":"bib99-20210131","doi-asserted-by":"crossref","first-page":"48684","DOI":"10.1074\/jbc.M308001200","article-title":"The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression","volume":"278","author":"Inman","year":"2003","journal-title":"J Biol Chem."},{"issue":"5","key":"bib100-20210131","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/bcr3048","article-title":"Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2\/CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin","volume":"13","author":"Mendoza-Villanueva","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"3","key":"bib101-20210131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10549-010-1261-9","article-title":"SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer","volume":"129","author":"Clausen","year":"2011","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"bib102-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bone.2012.10.009","article-title":"Novel SOST gene mutation in a sclerosteosis patient and her parents","volume":"52","author":"Bhadada","year":"2013","journal-title":"Bone."},{"issue":"6","key":"bib103-20210131","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bone.2005.02.019","article-title":"A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene","volume":"36","author":"Balemans","year":"2005","journal-title":"Bone."},{"issue":"4","key":"bib104-20210131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/gte.2008.0036","article-title":"A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin","volume":"12","author":"Kim","year":"2008","journal-title":"Genet Test."},{"issue":"2","key":"bib105-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet."},{"issue":"2","key":"bib106-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet."},{"issue":"6","key":"bib107-20210131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0022034509338340","article-title":"Sclerostin in mineralized matrices and van Buchem disease","volume":"88","author":"van Bezooijen","year":"2009","journal-title":"J Dent Res."},{"issue":"4","key":"bib108-20210131","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers","volume":"28","author":"van Lierop","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib109-20210131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2013","journal-title":"J Bone Miner Res."},{"key":"bib110-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2474-13-191","article-title":"Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis","volume":"13","author":"Taylan","year":"2012","journal-title":"BMC Musculoskelet Disord."},{"issue":"12","key":"bib111-20210131","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","article-title":"High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density","volume":"44","author":"Voskaridou","year":"2012","journal-title":"Horm Metab Res."},{"issue":"7","key":"bib112-20210131","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.joca.2011.04.014","article-title":"Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis","volume":"19","author":"Chan","year":"2011","journal-title":"Osteoarthritis Cartilage."},{"issue":"11","key":"bib113-20210131","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"3","key":"bib114-20210131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bone.2010.05.032","article-title":"Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats","volume":"47","author":"Tian","year":"2010","journal-title":"Bone."},{"issue":"12","key":"bib115-20210131","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/jbmr.182","article-title":"Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats","volume":"25","author":"Li","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib116-20210131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"7","key":"bib119-20210131","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jbmr.1608","article-title":"Absence of sclerostin adversely affects B-cell survival","volume":"27","author":"Cain","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"6","key":"bib120-20210131","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/leu.2011.381","article-title":"Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation","volume":"26","author":"Giuliani","year":"2012","journal-title":"Leukemia."},{"issue":"1","key":"bib121-20210131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.gastro.2010.09.007","article-title":"Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn\u2019s disease","volume":"140","author":"Oostlander","year":"2011","journal-title":"Gastroenterology."},{"issue":"10","key":"bib122-20210131","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1359\/jbmr.090403","article-title":"A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis","volume":"24","author":"Eddleston","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"1","key":"bib124-20210131","first-page":"101","article-title":"Osteocyte biology: its implications for osteoporosis","volume":"4","author":"Bonewald","year":"2004","journal-title":"J Musculoskelet Neuronal Interact."},{"issue":"3","key":"bib125-20210131","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bone.2011.11.021","article-title":"Increased proportion of hypermineralized osteocyte lacunae in osteoporotic and osteoarthritic human trabecular bone: implications for bone remodeling","volume":"50","author":"Carpentier","year":"2012","journal-title":"Bone."},{"issue":"6","key":"bib126-20210131","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/en.2009-1488","article-title":"Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice","volume":"151","author":"Weinstein","year":"2010","journal-title":"Endocrinology."},{"issue":"1","key":"bib127-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"10","key":"bib128-20210131","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201410010-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:36:05Z","timestamp":1787751365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201410010-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":124,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.m.01096","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}